Series AHealthUnited StatesMay 28, 2026

Secretome Therapeutics raises $30.0M Series A (United States, May 2026)

$30.0M
$30M Series A
Browse investors in United States →
Generated social card
Secretome Therapeutics social card
Headline

Secretome Therapeutics Raises $30M Series A for Cardiac Cell Therapy Expansion - Ventureburn

About

Secretome Therapeutics is focused on developing regenerative cardiac therapies, particularly targeting conditions like Duchenne muscular dystrophy associated cardiomyopathy. The company aims to restore and regenerate cardiac function through innovative cellular therapies, with recent funding set to advance their clinical trials and manufacturing capabilities.

Article summary

Secretome Therapeutics Raises $30M Series A for Cardiac Cell Therapy Expansion  Ventureburn

Investors · 1
RA Capital ManagementLead
FUND
Related rounds
Jun 11, 2026Current$80.0M—United States
Jun 11, 2026Endurance Energy$54.0MSeries AUnited States
Jun 11, 2026Neion Bio$23.0MSeries AUnited States
Jun 11, 2026Coram$35.0MSeries BUnited States
Secretome Therapeutics raises $30.0M Series A (United States, May 2026) | Datapile